GE HealthCare Technologies Inc. Stock BOERSE MUENCHEN

Equities

L0T

US36266G1076

Advanced Medical Equipment & Technology

Real-time BOERSE MUENCHEN 02:00:23 2024-07-12 am EDT 5-day change 1st Jan Change
73.5 EUR 0.00% Intraday chart for GE HealthCare Technologies Inc. +3.65% +6.52%
Sales 2024 * 20.13B 18.52B Sales 2025 * 21.11B 19.43B Capitalization 36.49B 33.58B
Net income 2024 * 1.84B 1.69B Net income 2025 * 2.11B 1.94B EV / Sales 2024 * 2.07 x
Net Debt 2024 * 5.24B 4.82B Net Debt 2025 * 3.22B 2.97B EV / Sales 2025 * 1.88 x
P/E ratio 2024 *
19.8 x
P/E ratio 2025 *
17.4 x
Employees -
Yield 2024 *
0.11%
Yield 2025 *
0.18%
Free-Float 93.06%
More Fundamentals * Assessed data
Dynamic Chart
1 week+3.65%
Current month+1.41%
1 month+5.68%
3 months-10.67%
6 months+6.52%
Current year+6.52%
More quotes
1 week
70.16
Extreme 70.16
74.00
1 month
69.50
Extreme 69.5
74.84
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 22-12-13
Director of Finance/CFO 51 23-05-31
Chief Tech/Sci/R&D Officer - 22-09-30
Members of the board TitleAgeSince
Director/Board Member 65 22-12-13
Chief Executive Officer 59 22-12-13
Chairman 60 23-01-02
More insiders
Date Price Change
24-07-12 73.5 0.00%
24-07-11 73.5 +1.02%
24-07-10 72.76 +2.75%
24-07-09 70.81 -0.13%
24-07-08 70.9 -0.21%

Real-time BOERSE MUENCHEN, July 12, 2024 at 02:00 am EDT

More quotes
GE HealthCare Technologies Inc. is a medical technology, pharmaceutical diagnostics, and digital solutions company. It develops, manufactures, and markets a portfolio of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients. Its segments include Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a comprehensive portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its Ultrasound segment includes ultrasound medical devices and solutions with a portfolio of continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment portfolio is comprised of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment is comprised of two business lines: contrast media and molecular imaging.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
79.94 USD
Average target price
92.55 USD
Spread / Average Target
+15.78%
Consensus